In contrast to previous studies, ApoE peptides can target multiple overexpressed low-density lipoprotein family receptors (LDLRs) (e.g., LDLR, LRP1, and LRP2) in BBB endothelial cells and GBM cells, thus providing superior BBB penetration and tumor targeting capabilities 208. Here, APOE is linked to glioblastoma.